PMID: 4316709Jan 1, 1970Paper

Mechanism of transmitter release

Progress in Biophysics and Molecular Biology
J I Hubbard

Abstract

No abstract listed.

References

Jan 1, 1969·Brain Research·K PfenningerC H Eugster
Mar 1, 1967·Canadian Journal of Physiology and Pharmacology·S P Bhatnagar, F C MacIntosh
Jan 1, 1968·Journal of Neurochemistry·I G Morgan, L Austin
Jan 1, 1966·Pflügers Archiv für die gesamte Physiologie des Menschen und der Tiere·M BraunM Zimmermann
Feb 1, 1968·The Journal of Physiology·J I Hubbard, S Kwanbunbumpen
Mar 1, 1968·The Journal of Physiology·B Katz, R Miledi
Apr 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·H Rasmussen, A Tenenhouse
Jan 1, 1968·Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie·T L SpriggsJ D Graham
Aug 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·A L Lehninger
Aug 26, 1968·Brain Research·D R Curtis, W C De Groat
Nov 1, 1968·The Journal of Physiology·Z L BliochV A Nenashev
Nov 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·D Nachmansohn
Dec 1, 1968·The Journal of General Physiology·R I BirksD R Firth
Jun 1, 1968·Journal of Theoretical Biology·P Kruckenberg, R Sandwig
Feb 1, 1969·The Journal of General Physiology·A A Auerbach, M V Bennett
Dec 1, 1968·The Journal of Physiology·B Katz, R Miledi
May 1, 1969·American Zoologist·R Fujii, R R Novales
Nov 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·A Alousi, N Weiner
Jan 31, 1967·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·B Katz, R Miledi
Jan 31, 1967·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·B Katz, R Miledi
Jan 31, 1967·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·B Katz, R Miledi
Dec 13, 1966·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·D P Dearnaley, L B Geffen
Mar 28, 1967·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·K Kapeller, D Mayor
Sep 1, 1967·Comparative Biochemistry and Physiology·M J Wood, G Burnstock
Feb 27, 1968·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·R Miledi, C R Slater
Jul 9, 1968·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·R I Birks, M W Cohen
Jul 9, 1968·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·R I Birks, M W Cohen
Aug 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·V P Whittaker
Sep 1, 1968·The Biochemical Journal·V P Whittaker
Jan 1, 1968·Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie·H Thoenen, J P Tranzer
Jan 1, 1969·The Journal of Physiology·F A DodgeR Rahamimoff
Jan 1, 1968·Zeitschrift für Zellforschung und mikroskopische Anatomie·A Pellegrino de Iraldi, R Gueudet
Jan 1, 1968·Zeitschrift für Zellforschung und mikroskopische Anatomie·J ZelenáE Gutmann
Dec 1, 1965·The Journal of Physiology·D Elmqvist, D S Feldman
Jun 1, 1966·Life Sciences·R H RothU S von Euler

❮ Previous
Next ❯

Citations

May 1, 1977·Annals of Neurology·S J Oh
Mar 1, 1972·Biulleten' eksperimental'noĭ biologii i meditsiny·O M Pozdniakov, A A Polgar
Jan 1, 1986·Neir̆ofiziologiia = Neurophysiology·E A BukharaevaR A Giniatullin
Sep 1, 1974·Medical & Biological Engineering·M E Greene, J W Clark
Dec 12, 1975·Brain Research·H L AtwoodC R Gruenwald
Dec 12, 1975·Brain Research·L E Swenarchuk, H L Atwood
Sep 1, 1974·European Journal of Pharmacology·J Zink, D Bose
Jan 1, 1983·Journal of the Neurological Sciences·M TakamoriS Okumura
Nov 1, 1992·Neuropharmacology·A FleischmannA M Etgen
Jan 1, 1972·Progress in Biophysics and Molecular Biology·P F Baker
Jan 1, 1973·Progress in Biophysics and Molecular Biology·H Reuter
Jan 1, 1974·Progress in Biophysics and Molecular Biology·A A Verveen, L J DeFelice
Oct 1, 1987·Regulatory Peptides·A BelaiG Burnstock
Jan 1, 1989·Neurochemistry International·S BernathM J Zigmond
Jan 1, 1976·Progress in Neurobiology·H L Atwood
May 1, 1984·Neuroscience·T KissI Benedeczky
Jan 4, 2001·Neurochemistry International·V Leviel
Nov 11, 1976·Proceedings of the National Academy of Sciences of the United States of America·D J DilibertoJ Axelrod
Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H YamashitaC M Brooks
Dec 1, 1978·Acta Physiologica Scandinavica·L GustafssonG Lundgren
Feb 1, 1982·Journal of Neurosurgery·O R Hubschmann, D Kornhauser
Nov 1, 1994·Survey of Ophthalmology·D A WeinbergT L Vollmer
Dec 1, 1977·Experimental Neurology·J W HaycockC W Cotman
Sep 1, 1972·Comparative Biochemistry and Physiology. A, Comparative Physiology·P N Usherwood, D Rees
Aug 4, 1978·Brain Research·C D Sladek, R J Joynt
May 18, 1972·The New England Journal of Medicine·G B Koelle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.